Free Trial
OTCMKTS:AUGX

Augmedix (AUGX) Stock Price, News & Analysis

Augmedix logo
$2.35 0.00 (0.00%)
(As of 10/2/2024)

About Augmedix Stock (OTCMKTS:AUGX)

Key Stats

Today's Range
$2.35
$2.35
50-Day Range
$2.35
$2.35
52-Week Range
$0.73
$6.25
Volume
N/A
Average Volume
635,746 shs
Market Capitalization
$115.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

Receive AUGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Augmedix and its competitors with MarketBeat's FREE daily newsletter.

AUGX Stock News Headlines

Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.
See More Headlines

AUGX Stock Analysis - Frequently Asked Questions

Augmedix's stock was trading at $5.85 at the beginning of the year. Since then, AUGX stock has decreased by 59.8% and is now trading at $2.35.
View the best growth stocks for 2024 here
.

Augmedix, Inc. (OTCMKTS:AUGX) issued its quarterly earnings data on Monday, March, 27th. The company reported ($0.15) EPS for the quarter, beating analysts' consensus estimates of ($0.16) by $0.01. The company earned $8.75 million during the quarter, compared to the consensus estimate of $8.52 million. Augmedix had a negative net margin of 57.70% and a negative trailing twelve-month return on equity of 980.09%.

Shares of AUGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Augmedix investors own include Meta Platforms (META), Urban Outfitters (URBN), Arista Networks (ANET), Capital Southwest (CSWC), NVIDIA (NVDA), PACCAR (PCAR) and Turkcell Iletisim Hizmetleri A.S. (TKC).

Company Calendar

Last Earnings
3/27/2023
Today
12/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
Business Services
Current Symbol
OTCMKTS:AUGX
Fax
N/A
Employees
710
Year Founded
N/A

Profitability

Net Income
$-24,450,000.00
Pretax Margin
-57.23%

Debt

Sales & Book Value

Annual Sales
$51.58 million
Book Value
$0.10 per share

Miscellaneous

Free Float
36,316,000
Market Cap
$115.07 million
Optionable
Not Optionable
Beta
-0.22
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

This page (OTCMKTS:AUGX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners